Concepedia

Publication | Open Access

LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)

DOIFull Paper Access

131

Citations

0

References

2023

Year

Thomas Powles, Begoña P. Valderrama, Shilpa Gupta, Jens Bedke, Eiji Kikuchi, Jean Hoffman‐Censits, Gopa Iyer, Christof Vulsteke, S.H. Park, Sang Joon Shin,
Annals of Oncology

No additional data available for this publication yet. Check back later!